Cambridge Cell Networks

Cambridge Cell Networks was a specialized bioinformatics and systems biology company that provided innovative software solutions and consultancy services for the pharmaceutical and chemical industries. The company focused on predictive toxicology and drug safety, utilizing its proprietary Tox-Geno-Ontology (TGO) platform to map molecular interactions and biological pathways. By integrating diverse data sources, Cambridge Cell Networks enabled researchers to better understand the mechanisms of action and potential side effects of chemical compounds. Their approach combined chemical structural information with biological pathway analysis to improve the accuracy of risk assessments. In 2014, the company was acquired by Molecular Networks GmbH, and its technologies were integrated into the Molecular Networks & Altamira (MN-AM) portfolio.